| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |